Although manufacturers are exempted from the obligation to perform clinical investigations for the types of implantable devices and class III devices listed in this Regulation, they are nonetheless required to plan, conduct and document a clinical evaluation in accordance with Article 61 of Regulation (EU) 2017/745 for those devices.
Recital 5, Regulation (EU) 2026/1451
In forcesince 20 Mar 2026